ulating specific PK signal transduction pathways, which regulate atherogenesis-related inflammatory cytokines TNF and IL-1.
Overexpression of macrophage scavenger receptors (MSR) 1 on activated macrophages and macrophage-derived foam cells in atherosclerotic lesions has been reported (2) (3) (4) (5) . Scavenger receptors mediate the high affinity binding and internalization of modified lipoproteins including OxLDL (6 -8) , implying an important role in lipid-laden foam cell formation during atherosclerosis development and progression. In addition to OxLDL, a diverse group of polyanionic compounds has been listed as ligands for MSR (9, 10) . The broad nature of ligand specificity in MSR may explain receptor-multifaceted functions of macrophages such as adhesion (11, 12) , clearance of pathologic substances (13, 14) , host defenses (9, 15) , and cytokine production (this paper and Refs. 9 and 16). However, the molecular mechanisms for MSR on macrophages possessing the capacity of cytokine induction remain unclear and need further investigation.
The activated macrophages not only transform into foam cells via uptake of OxLDL, but also aberrantly produce a battery of inflammatory cytokines that play pivotal roles in the process of atherogenesis. It has been demonstrated that interleukin-1␤ (IL-1) and tumor necrosis factor-␣ (TNF) (2, (17) (18) (19) are the major inflammatory cytokines (2, 18, 19) altering the function of macrophages in ways that appear to promote atherosclerosis (20) . Recent studies show that cytokines secreted from activated macrophages can be initiated or potentiated by one of the MSR ligands, OxLDL (21) , thus dysregulating expression of MSR and likely promoting the development of localized inflammatory reactions. Indeed, the macrophage-derived inflammatory cytokines IL-1 and TNF cause adjacent endothelial cellular expression of procoagulant activity, changing the endothelial cell surface from antithrombotic to thrombotic.
On the other hand, fucoidan, the principal polysaccharide sulfate ester occurring in the various species of Phaeophyceae (brown seaweed), although it is a non-lipoprotein, is recognized as an MSR ligand and effectively competes with OxLDL in MSR ligand binding studies (9, 10) . Up-regulation of MSR expression in human THP-1 monocytic macrophages upon phorbol 12-myristate 13-acetate priming has been reported (16, 22, 23) . Binding of fucoidan to MSR stimulates urokinase-type plasminogen activator secretion in human THP-1 macrophages (1), in activated peritoneal murine macrophages, and in murine macrophage cell lines (J774A.1 and RAW264.7) (24, 25) . The expression of uPA via MSR ligand-mediated signaling molecules include protein-tyrosine kinases (PTK), phospholipase C-␥1, phosphatidylinositol 3-kinase (PI 3-kinase), and protein kinase C (PKC), indicating a molecular model for regulation of urokinase-type plasminogen activator expression by the specific ligand of MSR (1) . Furthermore, herbimycin A (HB) inhibits fucoidan-induced tyrosine phosphorylation of phospholipase C-␥1 (1), suggesting that an unidentified PTK is involved in fucoidan-induced signaling. In this paper, we demonstrate again that geldanamycin (GA) or HB inhibits fucoidan-induced phosphorylation of various protein tyrosines and expression of IL-1. It is known that GA or HB inhibits the activation of certain tyrosine kinases; however, their cellular target is heatshock protein 90 (Hsp90) (26) , and its expression is induced by cell stress. Obviously, the MSR-induced cytokines IL-1 and TNF could lead to cellular stress including inflammation. Both GA and HB, benzoquinone ansamycin antibiotics, inhibit various signal transduction proteins including non-receptor protein-tyrosine kinase (NRPTK) pp60Src. Pharmacologically, HB or GA binds in a specific manner to Hsp90 and inhibits pp60Src⅐Hsp90 heterocomplex formation (26 -28) . Although ligands of MSR such as fucoidan and polyinosinic acid induce IL-1 production in human THP-1 macrophages (16), they are unable to examine systematically the MSR ligand-regulated signaling cascade for IL-1 production in macrophages. Hence, we propose and investigate pp60Src and Hsp90, which may play certain roles in fucoidan-mediated effects such as the association between pp60Src and Hsp90 in forming a complex in the regulation of fucoidan-induced prointerleukin 1␤ (proIL-1) protein expression.
In studies reported here, we observe tha both OxLDL and fucoidan up-regulate TNF production; additionally, fucoidan but not OxLDL induces proIL-1 protein and IL-1 secretion in murine macrophages J774A.1. We demonstrate for the first time that fucoidan differentially stimulates the signaling machinery including NRPTK, pp60Src, p21-activated kinase (PAK), and mitogen-activated protein kinases (MAPKs; i.e. ERK, JNK, and p38). Recent studies indicate that IL-1 secretion is post-transcriptionally regulated via IL-1 converting enzyme (ICE, caspase 1) (29 -32) . In here, we find that fucoidanmediated specific signals regulate IL-1 secretion, and simultaneously, fucoidan induces ICE activity during alternation of proIL-1/IL-1 expression. Moreover, combining with pharmacological inhibitors and genetic mutants in protein kinase assays, we investigate the molecular mechanism for MSR ligand-mediated signal transduction pathways in the regulation of proIL-1/IL-1 expression. Specifically, we further dissect and confirm the role of several key signaling molecules in induction of proIL-1, and we establish two signaling cascades, i.e. the PTK(Src)/Rac1/PAK/JNK pathway and the PTK(Src)/ Rac1/PAK/p38 pathway, in the regulation of proIL-1/IL-1 expression. Kinase Assay Kits-The p44/42 MAP kinase assay Kit, SAPK/JNK assay kit, and p38 MAP kinase assay kit were purchased from Cell Signaling Technology (Beverly, MA).
Protein Kinase Inhibitors-PD98059 was from Cell Signaling Technology. PP1 was from Biomol (Plymouth meeting, PA). Calphostin C, PP2, and HB were from Calbiochem-Novabiochem Corp. Wortmannin, LY294002, and SB203580 were from Sigma.
Oligonucleotides-Primers for TNF, proIL-1/IL-1, and glyceraldehyde phosphate dehydrogenase (GAPDH) were synthesized from local MD Bio. Inc. (Taipei, Taiwan). The dominant negative JNK construct (DN-JNK) was a gift from Dr. Michael Karin (UCSD, San Diego, CA) (33) . The dominant negative Rac1 construct (DN-Rac1) and constitutive activated Rac1 construct (CA-Rac1) were gifts from Dr. S. Bagrodia (Cornell University, Ithaca, NY) (34) . All detail methods and procedures have been presented previously (22, 35) .
Isolation of LDL for Preparation of

Analysis of ICE (Caspase 1) Activity
To analyze the ICE activity in J774A.1 cells we basically followed the protocols from the CaspACE ® assay system, fluorometric. Briefly, the cells were incubated with 25 g/ml fucoidan or 5 g/ml OxLDL. At the indicated time, the cells were washed twice with ice-cold phosphatebuffered saline (without Ca ϩ2 , Mg ϩ2 ), harvested in 300 l of cell suspension buffer (25 mM pH 7.5 HEPES, 5 mM MgCl 2 , 5 mM EDTA, 5 mM dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, 10 g/ml pepstatin A, 10 g/ml leupeptin, from Promega Co.). The suspended cells were stored in 1.5-ml centrifugation tubes, frozen and thawed three times, and then centrifuged at 12,000 ϫ g at 4°C for 15 min; the pellets were discarded. The protein concentration of supernatant in cell extract was determined, and the rest of the supernatant was saved at Ϫ80°C for future use. For assaying ICE activity, 32 l of ICE-like enzyme assay buffer, 2 l of dimethyl sulfoxide, and 10 l of 100 mM dithiothreitol were added to 75 g of protein of cell extract from tested samples at various times, and then adjusted with water to 98 l. For each tested sample there was a negative control (the same as above tested sample with the addition of 2 l of 2.5 mM ICE inhibitor (Ac-YVAD-CHO)) and a blank control (32 l of ICE-like enzyme assay buffer, 10 l of 100 mM dithiothreitol, 2 l of dimethyl sulfoxide, and 54 l of water). All tested samples were incubated at 30°C for 30 min. After the incubation, 2 l of 2.5 mM ICE substrate (Ac-YVAD-AMC) was added to each sample, followed by an additional 60-min incubation at 30°C; then the intensity of the fluorescence of the tested sample was measured at an excitation wavelength of 360 nm and an emission wavelength of 460 nm. Calculation of the relative fluorescence units and the caspase activity for each sample, as well as construction of standard curve and AMC calibration curves were as described in the Technical Bulletin from Promega Co.
Assay Activity of ERK, JNK, p38, and PAK in Fucoidan-treated
J774A.1 Cells with or without PK Inhibitors
Methods for assaying these PKs, including cell lysate preparation, immunoprecipitation of PK, in vitro PK reaction, analysis of PK activity, and quantification of PK activity were as described previously (35) . Methods for transfection and MAPK activity assays were as described (35) . Briefly, the conditions for growing J774A.1 cells to be transfected were identical to those of regular J774A.1 cells, except the cells were subpassaged the day before transfection and replaced with fresh medium. The transient transfection of DN-JNK, DN-Rac1, CARac1, or control (i.e. the empty expression vector) at 10 g of DNA/ 100-mm plate into cells was conducted by using LipofectAMINE PLUS ® reagent (Life Technologies, Inc.) as described previously (35) . The efficiency of both transfection and expression was monitored by the hemagglutinin tag expression. DN-Rac1-transfected cells were stimulated with fucoidan for 120 min and 240 min, respectively, then used to assay the activity of JNK and p38 as described above. DN-JNK-transfected cells and DN-Rac1-transfected cells were harvested after 24, 48, and 72 h (each sample was treated with fucoidan for 8 h), as well as CA-Rac1-stably transfected cells were harvested after fucoidan treatment for 4, 12, or 24 h, respectively. ProIL-1 protein expression in cells was detected by Western blotting analysis.
Transfection of DN-JNK
Statistical Analysis
Statistical differences between the experimental groups were examined by analysis of variance, and statistical significance was determined at p Ͻ 0.05. The experiments were conducted three times or as indicated, and all data are expressed as the mean Ϯ S.E. Cells were grown at various times in media with 5 g/ml native LDL, 5 g/ml OxLDL, 25 g/ml fucoidan, or with no supplement (i.e. as control). The released TNF in conditioned media was measured by enzymelinked immunosorbent assay (ELISA). Specifically, between 4 and 12 h, OxLDL-treated cells produced about 600 pg/ml TNF, or about 100% more TNF than those of LDL-treated or control cells (the background of TNF is about 300 pg/ml); after 24 h, the released TNF in OxLDL-treated cells returned to basal level (Fig. 1A) . In contrast, cells treated with fucoidan for 4 h began to increase the TNF released to about 15,000 and 30,000 pg/ml at 8 and 24 h, respectively (Fig. 1B) . We next determined whether TNF secretion in conditioned medium was reflected by increasing TNF message stimulated by OxLDL and fucoidan in J774A.1 cells. Using RT-PCR, we detected the alternation of TNF message between 2 and 24 h and found that no significant increase of TNF mRNA was observed in either fucoidan-treated cells (Fig. 1C) Fig. 2A , approximately 10 pg/ml IL-1 protein was detected in conditioned medium in 8-h fucoidan-treated cells compared with that of control cells or of native LDL-incubated cells (both below detectable level). The IL-1 concentration increased with prolonged fucoidan incubation time; at 48 h, the accumulated concentration of IL-1 in fucoidan-treated cells was up to 50 pg/ml. In contrast, OxLDL barely stimulated IL-1 secretion in the cells for all testing periods ( Fig. 2A) . Results indicate that in J774A.1 cells, ligation of different MSR ligands leads to differentially induced IL-1 protein secretion. Cumulative TNF is presented as the concentration of TNF in cell-conditioned medium treated with 5 g/ml OxLDL collected at the indicated time within 24 h and measured using an ELISA as described under "Experimental Procedures." The data are reported as representative of three experiments (n ϭ 3). Panel B, effect of fucoidan on TNF production in cells. Experiments and measurement for TNF production in 25 g/ml fucoidan-treated cells were similar to those described for panel A. One of three experiments is presented (n ϭ 3). Panel C, RT-PCR analysis of expression of TNF mRNA in cells. Total RNA was isolated from cells grown in serum-free medium in the presence of 5 g/ml OxLDL or 25 g/ml fucoidan for various times as indicated. For fucoidan treatment, ethidium bromide-stained agarose gel with amplified TNF cDNA at 692 base pairs (bp) and normalized by comparison with RT-PCR of mRNA of GAPDH at 450 bp, a constitutively expressed gene, are indicated with arrows for TNF and GAPDH, respectively. The detailed method is described under "Experimental Procedures." One of three experiments is presented (n ϭ 3). Results in OxLDL-treated cells were similar to the results of RT-PCR for TNF mRNA (data not shown).
RESULTS
Ligands of MSR
To investigate further the molecular mechanism of the secretion of mature IL-1 (17-18 kDa), initially the fucoidaninduced IL-1 precursor, proIL-1 (34 kDa) was detected by Western blotting analysis. As shown in Fig. 2B , fucoidan-induced proIL-1 protein was detected between 2 and 4 h and peaked at 8 h. After 12 h, proIL-1 protein decreased, and it gradually returned to basal level around 24 h. There was no detectable proIL-1 protein in OxLDL-treated cells for all periods (data not shown), consistent with no IL-1 secretion in OxLDL-treated cells. Moreover, using RT-PCR, we demonstrated 2-h fucoidan incubation, but not OxLDL-induced proIL-1 mRNA expression, compared with native LDL-treated cells or with control cells. The fucoidan-induced proIL-1 message peaked between 6 and 8 h (Fig. 2C) ; at 12 h, it remained higher than that of control cells. After 24 h, the induced proIL-1 message returned to basal level. The similar up-regulation of proIL-1 mRNA detected by Northern analysis is comparable to the message detected by RT-PCR (data not shown).
Post-transcriptional regulation and processing of proIL-1 protein into mature IL-1 secretion via ICE has been reported (31, 32) . Because incubation of cells with fucoidan induced proIL-1 protein and simultaneously led to IL-1 secretion in a timely fashion, we examined whether fucoidan stimulates ICE activity during IL-1 secretion. As shown in Fig. 2D , ICE activity increased 2-fold compared with control cells after a 6-h fucoidan stimulation; in contrast, there is no detectable ICE activity in OxLDL-treated cells. Hence, we focus on fucoidanmediated signal transductions including protein kinase in the regulation of proIL-1/IL-1 in J774A.1 cells.
Fucoidan Activates ERK in J774A.1 Cells-Our previous results demonstrated that fucoidan transduces PK signaling pathways in the up-regulation of urokinase-type plasminogen activator (1). To examine fucoidan-mediated signal transduction pathways in the regulation of IL-1 gene expression, first we tested whether fucoidan stimulates MAPK. Incubation of J774A.1 cells with fucoidan led to a modest phosphorylation of Elk-1, a transcriptional factor, evidencing the activation of ERK induced by fucoidan (Fig. 3A) . Experiments for the time course of fucoidan-induced ERK activity were further conducted. As detected by Western blot analysis with anti-phospho-Elk-1 antibody, which recognizes the activated, serine 383-phosphorylated form of Elk-1 by activated ERK (36) , ERK activity in untreated cells barely exists. Upon fucoidan stimulation, the activity of ERK was detected around 30 min, and it reached the maximal level of about 2-fold at 120 min; after 240 min, ERK activity gradually returned to basal level (Fig. 3, A and B) .
Role were incubated in the presence of 50 M fluorescent caspase 1 substrate Ac-YVAD-CHO for 1 h at 30°C. Caspase 1 activity was measured fluorometrically after substrate cleavage with excitation at 360 nm and emission at 460 nm. The detailed method is described under "Experimental Procedures" or as in the instruction manual of the CaspACE ® assay system, fluorometric, from Promega. Experiments were repeated three times, and a representative result is shown.
and simultaneously stimulates proIL-1 protein. We examined whether the PKC/MEK1/ERK pathway is one of fucoidan-induced PTK downstream signaling cascades in the regulation of proIL-1. Initially, experiments were conducted for dose responses of calphostin C (PKC inhibitor, 0.25, 0.50, 1.0, and 5.0 M) and of PD98059 (MEK1 inhibitor, 10, 25, 50, and 100 M) in inhibiting ERK activity. J774A.1 cells were exposed to the indicated concentrations of inhibitors, followed by incubation with fucoidan, and the appropriate concentrations of calphostin C and PD98059 inhibiting ERK activity were determined as 1.0 and 50 M, respectively (data not shown). Results of Western blotting analysis show that at the indicated concentration, neither calphostin C (Fig. 4A ) nor PD98059 (Fig. 4B ) blocks fucoidan-induced proIL-1 protein, although calphostin C and PD98059 effectively inhibit fucoidan-stimulated ERK activity, suggesting that the PKC/MEK1/ERK pathway is less involved in fucoidan-induced proIL-1 protein expression.
Fucoidan Stimulates JNK Activity and the Role of JNK in Fucoidan-induced ProIL-1 Protein-
The inflammatory response of J774A.1 cells to fucoidan resulting in induction of IL-1 expression suggested to us one possibility for fucoidan activation of the stress-related JNK pathway. We examined whether fucoidan activates JNK. Cells incubated with fucoidan led to JNK activation (Fig. 5A) as determined by Western blot analysis via anti-phospho-c-Jun, an antibody that recognizes the activated, serine 63-phosphorylated form of c-Jun (37, 38) . As in a time-course fashion, JNK activity gradually increased around 60 min, and the maximal activity of JNK was at 120 min, about 13-fold of untreated cells (Fig. 5, A and B) . After 240 min, the induced JNK activity gradually returned to basal level. To investigate the role of fucoidan-induced JNK activity, initially, we chose and examined curcumin (a JNK inhibitor) in the regulation of proIL-1 protein expression. As shown in Fig.  6A , increasing curcumin above 0.1 M gradually reduces fucoidan-induced proIL-1 protein, and completely inhibits proIL-1 protein at concentrations above 1 M. Alternatively, experiments of transient transfection of DN-JNK into J774A.1 cells were conducted, and we studied directly the role of induced JNK in the regulation of proIL-1. Results of Western blotting analyses indicate that upon fucoidan stimulation, there is about 10-fold less proIL-1 protein in DN-JNK-transfected cells than in control cells (Fig. 6B) ; in addition, no proIL-1 protein could be detected in the 48-and 72-h DN-JNKtransfected cells. Consistently, there is no detectable JNK activity in the fucoidan-treated DN-JNK cells (data not shown).
Fucoidan Stimulates p38 Activity and the Role of p38 in Fucoidan-induced ProIL-1 Protein-To explore additional fucoidan-mediated signal transduction pathways, we further examined whether fucoidan induces p38 activity, another important stress-related MAPK member. Upon fucoidan stimulation, p38 activity gradually increased as detected by Western blotting analysis with anti-phospho-ATF-2, an antibody that spe- cifically recognizes the activated, Thr-71-phosphorylated form of ATF-2 (39) (Fig. 7A) . The results of a time-course study of fucoidan-induced p38 activity indicated that at 60 min, p38 activity increased to 6-fold that of control cells. At 240 min, p38 activity of treated cells reached to about 10-fold that of control cells; after 480 min, it returned to basal level (Fig. 7, A and B) .
To dissect the effect of fucoidan-induced p38 activity in ATF-2 phosphorylation, we designed a series of experiments. Using a specific p38 inhibitor, SB203580 (SB), we initially conducted the inhibitory dose-response study of SB in fucoidan induction of p38 activity. J774A.1 cells were exposed to various concentrations of SB (0.1, 1.0, and 10 M) followed by incubation with fucoidan for various times. In the time-course study, SB effectively inhibits fucoidan-induced p38 activity at concentrations above 1 M compared with control untreated cells, although 0.1 M SB reduces p38 activity slightly (Fig. 8A) . Moreover, we further examined the potential role of fucoidaninduced p38 activation and ATF-2 phosphorylation in the regulation of proIL-1 protein. In J774A.1 cells pretreated with or without SB, followed by incubation with fucoidan, Western blotting analyses were conducted to study the SB inhibitory dose response (concentrations were 0.1, 1.0, and 10 M) in proIL-1 protein expression. SB completely inhibited fucoidaninduced proIL-1 protein at concentrations above 1 M compared with control cells (Fig. 8B, samples 6 and 8 versus sample 2) ; but no inhibition below 0.1 M (Fig. 8B, sample 4) .
Fucoidan Stimulates PAK Activity-To investigate further the possible upstream signaling networks involved in regulation of JNK or p38 activity, one of the relevant signaling molecules, PAK, was chosen. PAK activity in the time-course study was examined using an immunoprecipitated radioactive protein kinase activity assay, with phosphorylation of substrate, myelin basic protein (40) . As shown in Fig. 9, A and B, the maximal fucoidan-stimulated PAK activity in phosphorylation of myelin basic protein occurred at 30 min, and after 60 min the stimulated PAK activity returned to basal level.
Effect of Rac1 Transfection on Fucoidan-stimulated JNK and p38 Activity and the Effect of Rac1 Transfection on Fucoidaninduced ProIL-1 Protein Expression-Activation of Rac1
GTPase stimulates PAK activity in some cells (34) . To dissect the relationship of fucoidan-induced signal transduction among Rac1 and JNK and p38, experiments for transfection of the DN-Rac1 construct were conducted and examined JNK and p38 activity, respectively. Upon fucoidan stimulation, there was 10-fold lower JNK activity (Fig. 10A , sample 2 versus sample 1) and 5-fold lower p38 activity (Fig. 10B , sample 2 versus sample 1) in DN-Rac1-transfected cells than those of empty expression vector-transfected control cells (sample 1 in Fig. 10, A and B) . Obviously, without fucoidan stimulation, no JNK and p38 activity is detected in cells transfected with empty expression vector (sample 3 in Fig. 10, A and B) . To investigate further the role of Rac1 in proIL-1 protein expression, experiments for the effect of DN-Rac1 and CA-Rac1 on fucoidan-induced proIL-1 protein were conducted. Moreover, the effects of DN-Rac1 and CA-Rac1 on fucoidan-induced proIL-1 protein were investigated further. As shown in Fig. 10C , upon 8-h fucoidan stimulation, proIL-1 was expressed much less in DN-Rac1-transfected cells (i.e. the 24-, 48-, and 72-h post-DN-Rac1-transfected cells) than that of empty expression vector-transfected control cells. In contrast, upon 12-and 24-h fucoidan stimulation, there was more proIL-1 expression (a superinduction) in CA-Rac1-transfected cells than in control cells (Fig. 10D) . All of these results indicate that in fucoidan-induced signal transduction networks, Rac1 mediates JNK and p38 activity and further regulates proIL-1 protein expression.
Effect of the PI3-kinase Inhibitor, Wortmannin, on Fucoidaninduced JNK and p38 Activity and on Fucoidan Regulation of ProIL-1 Protein and IL-1 Secretion-As
demonstrated above, the PKC/MEK1/ERK pathway plays less of a role in fucoidan regulation of proIL-1 expression. To explore other fucoidanmediated signal transduction pathways involving in proIL-1 expression, we used wortmannin, an inhibitor of PI 3-kinase, to examine the potential role of PI 3-kinase in fucoidan activation of JNK or p38. In J774A.1 cells preincubated with or without wortmannin for 60 min, followed by treatment with fucoidan for an additional 120 or 240 min, the activity of JNK and p38 was examined. In the absence of wortmannin, fucoidan induced activity of JNK and p38 approximate 13-fold (Fig. 11A , sample 2 versus sample 1) and 10-fold (Fig. 11B , sample 2 versus sample 1), respectively, compared with control untreated cells (sample 1). Interestingly, in cells preincubated with wortmannin followed by treatment of fucoidan, JNK and p38 activity increased approximately 16-fold (Fig. 11A , sample 4 versus sample 1) and 23-fold (Fig. 11B, sample 4 versus sample 1) , respectively, compared with control untreated cells.
Moreover, the roles of PI 3-kinase in fucoidan regulation of proIL-1 protein and IL-1 secretion were examined. In cells preincubated with wortmannin for 60 min followed by exposure to fucoidan for an additional 8 h, proIL-1 protein in cell lysates was detected by Western blotting analysis. Results showed that preincubation of wortmannin in fucoidan-treated cells increases proIL-1 production significantly (Fig. 12A, sample 4 ) compared with fucoidan-treated cells or wortmannin-treated cells (Fig. 12A, sample 2 or sample 3) or compared with control untreated cells (Fig. 12A, sample 1) . In addition, the effect of wortmannin on fucoidan-induced mature IL-1 secretion detected by ELISA was examined. There was a 5-fold higher IL-1 secretion (20 pg/ml) detected in cells pretreated with wortmannin prior to incubation with fucoidan (Fig. 12B, sample 4 ) compared with cells (4 pg/ml) incubated only with fucoidan (Fig. 12B, sample 2) ; as expected, no IL-1 was in the control cells (Fig. 12B, sample 1) . Without fucoidan, wortmannin slightly increased IL-1 secretion in cells (Fig. 12B, volves MSR ligand-mediated signal transductions. Preincubation of J774A.1 cells with specific inhibitors of pp60Src, e.g. PP1 or PP2, was followed by exposure to fucoidan. First, cell lysates were immunoprecipitated with monoclonal antipp60Src IgG, and immunocomplexes were recovered via incubation with protein A/G plus agarose. Immunoprecipitates were separated by SDS-polyacrylamide gel electrophoresis, then immunoblotted with monoclonal anti-phosphotyrosine IgG. As seen in Fig. 13A , the 60-kDa phosphotyrosyl protein was immunoreactive with anti-pp60Src IgG in fucoidantreated cells (sample 2) and less reaction in PP2-preincubated cells (sample 4). In contrast, there was no difference of tyrosine phosphotyrosine between PP1-preincubated cells and control untreated cells (samples 3 and 1) . These data indicate that ligation of fucoidan to MSR in J774A.1 cells leads to tyrosine phosphorylation of pp60Src, but PP1 and PP2 inhibit tyrosine phosphorylation.
HB inhibits fucoidan-stimulated protein tyrosine phosphorylation (1), suggesting that unidentified PTK involve fucoidan-mediated signals such as stress-related JNK and p38 activity. It is known that one of the HB cellular targets is Hsp90 (26) , which is expressed under certain stress conditions. GA and HB inhibit signal transduction proteins including NRPTK and pp60Src. Pharmacologically, GA and HB bind in a specific manner to Hsp90 and inhibit pp60Src⅐Hsp90 heterocomplex formation (26 -28) . Here in J774A.1 cells preincubated with GA and HB as well as PP1 and PP2 followed by exposure to fucoidan, we evaluated further the association (interaction) of pp60Src and Hsp90 by performing immunoprecipitation with anti-Hsp90 IgG and probing the resultant blots with antipp60Src IgG (Fig. 13B) . Whereas pp60Src co-precipitated with Hsp90 in fucoidan-treated cells (sample 2), interaction between (Fig. 14, samples 3 and 4 versus sample 2) in a dose-response study (data not shown). In contrast, fucoidan-induced proIL-1 protein can be partially reduced by inhibitors of pp60Src (PP1 or PP2) (Fig. 14, samples 5 and 6 versus sample 2); relatively, PP1 exerts more inhibitory effect than that of PP2 (Fig. 14, sample 5 versus sample 6) . Similarly, there was no detectable IL-1 secretion in cells pretreated with these inhibitors (data not shown).
DISCUSSION
In atherosclerotic lesions, activated macrophages via overexpressed scavenger receptors aberrantly taking up OxLDL are also the main source of secretion of inflammatory cytokines TNF (2, (17) (18) (19) and IL-1 (17, 19 ). Yet it is unclear whether there is a relationship between receptor ligand binding and stimulation of cytokine expression. Fucoidan, a polyanionic polysaccharide, has been used as an effective competitor for OxLDL or modified LDL in studies of receptor binding (9, 10). Moreover, fucoidan stimulates production of proteases (1, 9, 24) and cytokines in macrophages (9, 16 , and this paper); however, there is no molecular mechanism to date for fucoidan-mediated reactions. Using ELISA, we demonstrate here that 24-h fucoidan induces about 50-fold more TNF production than OxLDL does in J774A.1 cells. Based on the time course of TNF production (Fig. 1, A versus B) , there are different patterns and mechanisms for TNF induction by the two ligands, although TNF preexists in untreated cells. In addition, only the relatively lower concentration of OxLDL (5 g/ml) induced TNF because there was no induction of TNF at a higher concentration of OxLDL (50 g/ml) (data not shown), comparable to the previous demonstration (21) . Using RT-PCR for TNF mRNA, there was no apparent difference of TNF message among cells treated with fucoidan and OxLDL and untreated cells. The fact that there was increased TNF production but no alteration of TNF message under fucoidan stimulation indicates that fucoidan regulation of TNF expression is likely at a post-transcriptional level.
Neither IL-1 nor proIL-1 preexists in quiescent J774A.1 cells. Upon fucoidan stimulation, IL-1 can be detected by ELISA after 6 -8 h; IL-1 secretion is consistent with the sequential times for synthesis of proIL-1 mRNA and proIL-1 protein under stimulation for 2 and 4 h, respectively. The ICE FIG. 11 . Effect of the PI 3-kinase inhibitor wortmannin on fucoidan-induced JNK and p38 activity in J774A.1 cells. Panel A, effect of wortmannin on fucoidan-stimulated JNK activity. Cells were pretreated with 25 M wortmannin for 1 h prior to stimulating with 25 g/ml fucoidan for an additional 120 min followed by nonradioactive method for JNK assay as described previously. Panel B, effect of wortmannin on fucoidan-stimulated p38 activity. Cells were pretreated with 25 M wortmannin for 1 h prior to stimulating with 25 g/ml fucoidan for an additional 240 min followed by a nonradioactive p38 kinase assay as described previously. All data of relative JNK and p38 activity are expressed as a comparison with untreated cells (t ϭ 0; activity of control cells is 1). Similar results were obtained in four separate experiments. 3) and fucoidan-treated (samples 2 and 4). For fucoidantreated groups cells were incubated with 25 g/ml fucoidan for an additional 8 h. After treatments, the samples were subjected to Western blot analysis of proIL-1 as described above. This experiment is representative of three similar experiments. Panel B, effect of wortmannin on fucoidan-induced IL-1 secretion. Cells were treated as described in panel A. After the indicated treatments, concentrated conditioned media were collected at 8 h. The IL-1 contents in tested samples were assayed by an IL-1-specific ELISA as described above. The data are reported as representative of four separate experiments (n ϭ 4). activity of fucoidan-treated cells peaks around 6 h and simultaneously IL-1 secretion increases, which reflects that active ICE hydrolyzes proIL-1 into IL-1 as in various cells (31, 32) , although the reason for continuous increasing IL-1 needs further study. Our results indicate that there are complicated mechanisms, likely at transcriptional, post-transcriptional, and post-translational levels for fucoidan induction of proIL-1 protein and IL-1 secretion in macrophages. Surprisingly, there is no detectable expression of proIL-1/IL-1 in the cell incubated with OxLDL. One of explanations for the results is that binding of different ligands to the conserved lysine clusters of the collagen-like domain in MSR (43-45) may trigger on different signal transductions (44, 45) . 2 For the first time we demonstrate that different MSR ligands transduce diverse signaling and further lead to different biochemical reactions such as cytokine production.
Ligation of MSR induces signal transduction pathways in macrophages (1, 16, 46, 47) ; for example, binding of fucoidan to MSR in human monocytic macrophage THP-1 cells induced PKC signaling-mediated IL-1 secretion (16) and also stimulated protein tyrosine phosphorylation including phospholipase C-␥1, PI 3-kinase, and PKC activity leading to up-regulated urokinase-type plasminogen activator expression (1). To focus further on molecular mechanism by which fucoidan mediates signaling cascades including MAPK in regulation of proIL-1/ IL-1 expression, we utilized specific pharmacological antagonists such as calphostin C, PD98059, wortmannin, curcumin, and SB203580, which inhibit the phosphorylation of PKC (1, 48) , MEK1 (49), PI 3-kinase (50), JNK (51, 52) , and p38 (53), respectively. Because PKC and MEK1 are involved in the induction of ERK activity (54) , and ligation of fucoidan induces ERK activity, we examined the roles of PKC and MEK1 in fucoidan regulation of proIL-1/IL-1. Initially, both calphostin C and PD98059 inhibit fucoidan-stimulated ERK activity, but they fail to block fucoidan-induced proIL-1 protein and IL-1 secretion. Results indicate that the fucoidan-induced PKC/ MEK1/ERK pathway is not involved in regulating proIL-1/IL-1 expression, although we could not rule out the possibility of cross-talking between MEK kinase members and ERK. Similarly, using pharmacological inhibitors and genetic dominant mutants, we established a fucoidan-mediated signaling relationship among JNK and p38 activity and regulation of proIL-1 protein expression. In preliminary studies, we determined whether OxLDL or fucoidan induce cytokines in fully differentiated human macrophages. Peripheral blood monocytes were allowed to differentiate in culture at indicated times, and conditioned medium and cell lysates were collected and prepared. Exposure of monocyte-derived macrophages to OxLDL or fucoidan increased TNF secretion as detected by ELISAs; but only fucoidan induced proIL-1/IL-1 expression. Moreover, fucoidan activated ERK, JNK, and p38 in human macrophages examined by protein kinase assays, similar to those in J774A.1 cells.
Upstream signaling molecules, Rac1 and Cdc42, activating JNK activity have been reported (55, 56) , and likely p38 activity is activated in a similar way (57) . The PAK family of protein kinase has been recognized as one of the main targets to interact with the GTPases of Rac1/Cdc42 and generating downstream signaling networks (58) . We demonstrate that fucoidan quickly stimulates PAK activity followed by increasing the activity of JNK and p38, as well as induction of proIL-1 protein.
The current results of fucoidan-induced PAK, JNK, and p38 activity are comparable to the recent demonstration of Rac1 activation of PAK-mediated signals (59) , leading to induction of activity of JNK (34) and p38 (57), respectively. Upon fucoidan stimulation, DN-Rac1-transfected cells express lower activity of JNK and p38 (Figs. 4B and 10A ) as well as less proIL-1 protein production (Fig. 10C) than those of empty expression vector-transfected control cells. Moreover, fucoidan induces higher JNK and p38 activity 2 and more proIL-1 protein production (Fig. 10D) in CA-Rac1-stably transfected J774A.1 cells than those of control cells. Together, the results of using various Rac1 genetic mutants support that the levels of Rac1 and PAK are at the upstream of JNK and p38. In addition, we demonstrate the important roles in fucoidan-mediated signaling pathways of PTK/Rac1/PAK/JNK and of PTK/Rac1/PAK/ p38 in regulating proIL-1 expression. Furthermore, inhibitors of PI 3-kinase, wortmannin and LY294002 (data not shown) up-regulate JNK and p38 activity as well as increase proIL-1 protein and superinduce IL-1 secretion, suggesting that under normal conditions, endogenous PI 3-kinase and/or PI 3-kinaserelated downstream signals inhibit fucoidan-stimulated JNK and p38 activity and further suppress fucoidan-induced proIL-1/IL-1 expression.
Our results demonstrate that ligation of fucoidan to MSR induces multiple protein kinases activity, mitogen-like signals, and stimulation of proIL-1/IL-1 expression in macrophages, comparable to cells treated with certain cytokines (35, 60 -63) . There is no functional tyrosine kinase motif in the MSR cytoplasmic domain (9, (41) (42) (43) ; however, engagement of MSR with fucoidan quickly triggers HB-blockable protein tyrosine phosphorylation (1). Here, using specific inhibitors, we further demonstrate for the first time that fucoidan-mediated signals are via MSR, likely associated with cytosolic tyrosine kinase, e.g. pp60Src in concert with Hsp90; or via other receptor(s), but which, if any, of these mediate signal transductions and regulate proIL-1 protein and IL-1 secretion needs more study. Although the physiologic ligands for MSR are currently unknown, in comparing the polysaccharide structure of fucoidan with the relevant structure of another MSR ligand, lipopolysaccharide (9, 14) , fucoidan might exert lipopolysaccharide-like signals such as activation of MAPKs and induction of IL-1 (64) . 2 Phosphatidylserine, one of the effective competitors for MSR binding (9) , translocates from the inner face of the cell plasma membrane to the cell surface after initiating apoptosis. The role for MSR in the phagocytosis and clearance of apoptotic thymocytes has been reported (65) , and it is likely that phosphatidylserine on dying cells becomes an endogenous ligand of MSR upon apoptosis. Besides, another MSR ligand is advanced glycation end products of protein related to age-enhanced disease processes including atherosclerosis, which are endocytically taken up by scavenger receptors on macrophages (66) . Considering the physiological relevance of our observations in fucoidan-mediated signals and the potential endogenous ligand(s) as fucoidan, we speculate that similar transducing signals might arise upon the ligation of MSR, and the sequential biological impacts need further investigation.
In summary, continuing to expose MSR as a functional signaling receptor, we are the first to examine that MSR ligands induce several transducing signal cascades differentially, and further we systematically to dissect the molecular mechanisms by which fucoidan-mediated signals regulate IL-1. Specifically, we establish signal transduction pathways of PTK(Src)/Rac1/ PAK/JNK and PTK(Src)/Rac1/PAK/p38 in the regulation of proIL-1 protein and IL-1 secretion (Fig. 15) . In contrast, although fucoidan induces activity of PKC, MEK1, and ERK, there is less role for the pathway of PTK/phospholipase C-␥1/ PKC/MEK1/ERK in proIL-1/IL-1 regulation (Fig. 15) . On the other hand, fucoidan-induced ICE activity results in the alternative relationship between degradation of proIL-1 protein and increase of mature IL-1 secretion with time, suggesting that fucoidan probably mediates transcriptional, post-transcriptional, and post-translational regulation of IL-1 expression. Moreover, considering the important role of IL-1 in stimulating inflammatory abnormality, the model for ligation of MSR-mediated signal transduction pathways in regulating proIL-1/IL-1 expression provides certain biological significance in the development of vascular-related diseases.
